Hormonal
Medium-term supervised exercise (12 weeks) in overweight/obese individuals increases fasting acylated ghrelin (AG) and subjective hunger, indicating an orexigenic drive, but simultaneously improves postprandial satiety efficiency through enhanced suppression of AG and increased late-phase GLP-1 release.
If you start a moderate-intensity exercise program (like brisk walking or jogging at 75% max heart rate) 5 days a week for 3 months, expect to feel hungrier when you wake up or between meals. This is a normal hormonal response (increased ghrelin). However, this hunger is counterbalanced by your body becoming more efficient at signaling fullness after you eat. Focus on the post-meal satiety benefits rather than fearing the fasting hunger, as this may help you maintain a calorie deficit more sustainably than dieting alone.
Exercise-induced weight loss is associated with physiological and biopsychological changes toward an increased drive to eat in the fasting state. However, this seems to be balanced by an improved satiety response to a meal and improved sensitivity of the appetite control system.
Why this rating
Randomized controlled trial with a supervised exercise intervention and rigorous hormonal sampling, though sample size is small (n=15).
Source
The Effects of Exercise-Induced Weight Loss on Appetite-Related Peptides and Motivation to Eat
Cátia Martins et al. · The Journal of Clinical Endocrinology & Metabolism · 2010
DOI 10.1210/jc.2009-2082
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →